Long-term structural growth potential driven by anticipated shortage and price increases prompted investors to shuffle their bets in favour of pharma companies. On Wednesday, the BSE Healthcare index was the top sectoral performer.
Citi downgrades US stocks to ‘neutral’ as AI sell-off, regulatory risks mount
Citigroup strategists have downgraded US equities to neutral due to ongoing market volatility and regulatory concerns. This decision follows a significant sell-off that erased $3